Ortin Laboratories Ltd.

21.10 -0.05 ▼-0.2%

21 February 2024, 04:02:30 PM
Volume: 14,763

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ortinlabsindia.com
Market Cap 17.41 Cr.
Enterprise Value(EV) 23.09 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -5.01 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.82 Trailing Twelve Months Ending 2023-12
Book Value / Share 8.57 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.50 Calculated using Price: 21.41
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.81 Cr. 8,131,392 Shares
FaceValue 10
About Ortin Laboratories Ltd.
Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Ortin Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Ortin Laboratories Ltd. Performance

1 Day
-0.24%
1 Week
+2.18%
1 Month
-0.24%
3 Month
+10.47%
6 Month
+8.76%
1 Year
-6.43%
2 Year
-24.24%
5 Year
+62.93%
10 Year

Ortin Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 4.04 3.65 2.16 2.86 5.21 -2.31 5.38 -3.57 -0.86
Return on Capital Employed (%) 11.55 11.01 9.58 10.14 11.76 8.93 3.27 1.56 1.66
Return on Assets (%) 1.28 1.25 0.79 1 1.43 -0.51 1.37 -1.9 -0.45

Ortin Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 22 23 23 24 25 24 11 11 11 10
Non Curr. Liab. 8 16 8 8 8 9 2 2 3 3
Curr. Liab. 37 27 31 42 72 84 8 8 7 6
Minority Int.
Equity & Liab. 68 66 62 74 105 117 21 21 21 18
Non Curr. Assets 24 35 23 21 23 24 15 15 15 15
Curr. Assets 44 31 38 52 82 92 6 6 7 4
Misc. Exp. not W/O
Total Assets 68 66 62 74 105 117 21 21 21 18

Ortin Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 60 63 67 80 168 197 8 8 6 3
Other Income 0 1 0 0 1 0 0 0 0 0
Total Income 61 64 67 80 168 198 8 8 6 3
Total Expenditure -54 -57 -61 -74 -162 -192 -7 -8 -6 -7
PBIDT 7 6 6 6 7 6 1 1 1 -3
Interest -4 -3 -3 -3 -3 -3 -1 -1 0 -1
Depreciation -2 -2 -2 -2 -2 -2 0 0 0 0
Taxation 0 -1 -1 -1 -1 1 0 0 0
Exceptional Items 0
PAT 1 1 1 1 1 -1 1 0 0 -4
Adjusted EPS 1 0 0 0 1 0 1 0 0 -5

Ortin Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -2 -1 1 2 2 7 3 18 2 0
Cash Fr. Inv. 0 0 -1 -1 -1 -3 -3 0 0 0
Cash Fr. Finan. 1 2 0 -1 0 -3 -1 -10 0 1
Net Change -1 1 0 0 1 0 -1 8 2 1
Cash & Cash Eqvt 1 2 2 -14 -13 -13 -14 -5 -4 -3

Ortin Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 15.68 15.68 15.68 15.68 15.68 21.51 7.36 7.37 7.36
Public 84.32 84.32 84.32 84.32 84.32 78.49 92.64 92.63 92.64
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Ortin Laboratories Ltd. Announcements

Sat, 17 Feb 2024
Financial Result Updates
Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023.
Thu, 15 Feb 2024
Copy of Newspaper Publication
Ortin Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
Tue, 13 Feb 2024
Outcome of Board Meeting
Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on February 13, 2024.

Ortin Laboratories Ltd. Technical Scans

Wed, 21 Feb 2024
Opening at High Opening at High
Closing Near 20 SMA Closing Near 20 SMA
MFI Trending Down MFI Trending Down
Tue, 20 Feb 2024
High Increase in 3 Months High Increase in 3 Months
Closing Near 20 SMA Closing Near 20 SMA

Ortin Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 370,313.36 1,543.40 +0.3%
Cipla Ltd. 116,866.14 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. 105,898.11 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. 97,179.74 6,760.15 +0.0%
Divi's Laboratories Ltd. 96,854.88 3,649.10 -1.7%
Zydus Lifesciences Ltd. 90,440.44 893.80 -0.2%
Torrent Pharmaceuticals Ltd. 88,043.20 2,603.00 -1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.58 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 31.52 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.12 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 70.03 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.41 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 58.93 2,603.00 -1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.94 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 4.51 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.39 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.65 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.31 2,603.00 -1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,603.00 -1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,603.00 -1.6%

Ortin Laboratories Ltd. FAQ's

What is Ortin Laboratories share price?

Can I buy Ortin Laboratories shares now?

What is the Market Cap of Ortin Laboratories?

What are the key metrics to analyse Ortin Laboratories?

What is the 52 Week High and Low of Ortin Laboratories?

What is the trend of Ortin Laboratories share price?